L-163082

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameL-163082
Drug Alias NameN/A
ClassificationOther
Mechanisms of ActionAngiotensin II receptor type 2 antagonistsAngiotensin I antagonists
TargetsAngiotensin IAngiotensin II receptor type 2
Therapy Area/IndicationsCoronary Restenosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMerck & Co
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMerck & Co
Active IndicationsN/A
Inactive IndicationsCoronary Restenosis

Other Information

ATC CodeN/A
Related LinksN/A